10-QPeriod: Q1 FY2001

BECTON DICKINSON & CO Quarterly Report for Q1 Ended Dec 31, 2000

Filed February 12, 2001For Securities:BDX

Summary

Becton Dickinson & Co. (BDX) reported revenues of $843.3 million for the quarter ending December 31, 2000, a 2% decrease compared to the same period last year. This decline was primarily attributed to unfavorable foreign currency translation, which reduced revenues by an estimated $46 million, and a tough comparison to the prior year that benefited from year 2000-related inventory stocking. Despite the revenue dip, the company saw strong growth in safety-engineered products across its segments. Net income for the quarter was $60.6 million, or $0.23 per diluted share, down from $75.3 million, or $0.29 per diluted share, in the prior year. The company's financial condition remains solid, with total debt representing 40.8% of total capital as of December 31, 2000, down from 46.3% a year prior. BDX continues to manage its business through various strategic initiatives, including restructuring programs aimed at improving cost structure, and has adopted new accounting standards for derivative instruments. While facing ongoing legal proceedings, the company believes these will not have a material adverse effect on its consolidated financial condition.

Key Highlights

  • 1Revenue decreased by 2% to $843.3 million for the quarter ended December 31, 2000, largely due to a 5% negative impact from foreign currency translation.
  • 2Net income declined to $60.6 million from $75.3 million in the prior year's comparable quarter, resulting in diluted EPS of $0.23, down from $0.29.
  • 3Medical Systems segment revenues decreased by 5% to $438.4 million, impacted by currency fluctuations and inventory adjustments, though safety-engineered product sales showed good growth.
  • 4Clinical Laboratory Solutions and Biosciences segments reported modest revenue growth of 2% each, with Clinical Lab revenue growing 7% excluding currency impact.
  • 5The company adopted SFAS No. 133 regarding derivative instruments and hedging activities, impacting other expense/income.
  • 6Total debt as a percentage of total capital decreased to 40.8% from 46.3% in the prior year, indicating improved financial leverage.
  • 7Restructuring charges were recognized for ongoing programs aimed at improving cost structure, with a significant portion of targeted employee severances completed.

Frequently Asked Questions

The primary driver of the revenue decline was the unfavorable impact of foreign currency translation, particularly related to the Euro, which reduced reported revenues by an estimated $46 million. Additionally, a difficult comparison to the prior year's first quarter, which benefited from year 2000-related inventory stocking, and ongoing inventory reductions at the trade level also contributed to the decrease.

The adoption of SFAS No. 133, 'Accounting for Derivative Instruments and Hedging Activities,' effective October 1, 2000, required derivatives to be recorded at fair value. This led to a shift in how certain currency option gains and losses are recognized. For this quarter, the adoption resulted in hedging expenses recorded in 'other expense, net,' and a gain related to the effective portion of cash flow hedges included in other comprehensive income, impacting the 'Other expense (income), net' line item compared to the prior year.

Becton Dickinson is involved in various legal proceedings, including product liability and environmental matters. While it's not possible to predict the outcome, the company believes that, individually and in the aggregate, these matters are not expected to have a material adverse effect on its consolidated financial condition. Updates were provided on latex glove claims, needle-stick cases, and specific patent litigations with B. Braun and Critikon, with settlements or agreements reached or in progress.

Total debt as a percentage of total capital (shareholders' equity, net non-current deferred income tax liabilities, and debt) decreased to 40.8% as of December 31, 2000, from 46.3% in the prior year. This indicates a strengthening of the company's balance sheet and a reduced reliance on debt financing relative to its equity base.